Go Deep
Poly Medicure Limited
Poly Medicure Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,500 | 51.7 | 5.24 | 0.11 | 1,605.20 |
| Oct 2026 | 21,899 | 51.1 | 5.18 | 0.11 | 1,587.10 |
Poly Medicure Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 5,253,755,000.0 | 5,345,114,000.0 | 4,936,555,000.0 | 4,438,816,000.0 |
| Net Profit | 860,252,000.0 | 650,410,000.0 | 709,302,000.0 | 918,350,000.0 |
| EPS | 8.5 | 6.5 | 7.0 | 9.1 |
Poly Medicure Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 18,752,592,000.0 | 16,698,316,000.0 | 13,656,937,000.0 | 11,086,582,000.0 | — |
| Net Profit | 3,312,921,000.0 | 3,385,572,000.0 | 2,582,597,000.0 | 1,792,825,000.0 | — |
| EPS | 31.8 | 34.1 | 26.9 | 18.7 | — |
Poly Medicure Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 39,185,672,000.0 | 31,924,522,000.0 | 18,586,719,000.0 | 15,772,092,000.0 | — |
| Total Liabilities | 7,693,240,000.0 | 4,267,943,000.0 | 3,886,184,000.0 | 3,355,820,000.0 | — |
| Total Equity | 31,061,727,000.0 | 27,656,579,000.0 | 14,700,535,000.0 | 12,416,272,000.0 | — |
Owes vs Owns
Poly Medicure Limited owed ₹0.20 for every ₹1 it owned in Mar 2026, down from ₹0.21 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.20× | 0.13× | 0.21× | 0.21× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Poly Medicure Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 22.3%Receivables 13.6%Inventory 11.1%Fixed assets (tangible) 34.5%Intangible assets 11.2%Other assets 7.0%
How it's funded — Mar 2026
Short-term debt 7.4%Long-term debt 1.3%Payables 3.1%Other liabilities 7.8%Shareholders' equity 80.4%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 872.5 | 1,207.5 | 286.0 | 301.3 |
| Receivables | 531.2 | 349.7 | 269.9 | 235.4 |
| Inventory | 433.8 | 285.6 | 221.0 | 208.7 |
| Fixed assets (tangible) | 1,353.6 | 1,178.3 | 921.0 | 699.4 |
| Intangible assets | 439.1 | 55.2 | 53.6 | 50.1 |
| Long-term investments | 15.2 | 13.2 | 7.1 | 7.6 |
| Other assets | 273.1 | 102.9 | 100.0 | 74.7 |
| Liabilities & equity | ||||
| Short-term debt | 289.5 | 177.6 | 169.1 | 128.9 |
| Long-term debt | 52.1 | 0.0 | 0.8 | 17.5 |
| Payables | 122.7 | 86.4 | 95.6 | 92.3 |
| Other liabilities | 305.0 | 162.7 | 123.1 | 96.8 |
| Shareholders' equity | 3,149.2 | 2,765.7 | 1,470.1 | 1,241.6 |
| Net tangible assets | 2,667.1 | 2,710.5 | 1,416.5 | 1,191.5 |
Poly Medicure Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 2,463,746,000.0 | 2,330,497,000.0 | 2,660,822,000.0 | 1,910,520,000.0 | — |
| Investing Activities | -2,253,811,000.0 | -11,871,821,000.0 | -2,409,380,000.0 | -1,792,416,000.0 | — |
| Financing Activities | 201,514,000.0 | 9,505,058,000.0 | -201,535,000.0 | -125,053,000.0 | — |